Literature DB >> 10428904

Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis.

O J Billington1, T D McHugh, S H Gillespie.   

Abstract

Drug-resistant Mycobacterium tuberculosis is a major threat to public health. In clinical practice, a limited number of resistance mutations in a short sequence of the beta subunit of RNA polymerase (encoded by rpoB) have been described. Spontaneous resistance to rifampin was induced in vitro in M. tuberculosis H37Rv (ATCC 9360). Only three resistance patterns could be detected by PCR-single-strand conformation polymorphism analysis. Sequence analysis revealed that Ser(531)-->Leu arose most frequently, followed by His(526)-->Arg and then either His(526)-->Tyr or His(526)-->Asp. The relative Darwinian fitness of all but one of the mutant genotypes was less than that of the susceptible parent and, for these mutations, there was a significant correlation between fitness and clinical isolation rate (regression analysis P = 0.026). The fitness deficit in some mutants was small, suggesting that there is little likelihood of a spontaneous reversion to susceptibility.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428904      PMCID: PMC89382     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  The estimation of the bactericidal power of the blood.

Authors:  A A Miles; S S Misra; J O Irwin
Journal:  J Hyg (Lond)       Date:  1938-11

2.  Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays.

Authors:  T R Gingeras; G Ghandour; E Wang; A Berno; P M Small; F Drobniewski; D Alland; E Desmond; M Holodniy; J Drenkow
Journal:  Genome Res       Date:  1998-05       Impact factor: 9.043

3.  Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance.

Authors:  M Lipsitch; B R Levin
Journal:  Int J Tuberc Lung Dis       Date:  1998-03       Impact factor: 2.373

4.  Expression of tetracycline resistance in pBR322 derivatives reduces the reproductive fitness of plasmid-containing Escherichia coli.

Authors:  S W Lee; G Edlin
Journal:  Gene       Date:  1985       Impact factor: 3.688

5.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.

Authors:  A Telenti; P Imboden; F Marchesi; D Lowrie; S Cole; M J Colston; L Matter; K Schopfer; T Bodmer
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

6.  Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance.

Authors:  D J Jin; C A Gross
Journal:  J Mol Biol       Date:  1988-07-05       Impact factor: 5.469

7.  An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome.

Authors:  B R Edlin; J I Tokars; M H Grieco; J T Crawford; J Williams; E M Sordillo; K R Ong; J O Kilburn; S W Dooley; K G Castro
Journal:  N Engl J Med       Date:  1992-06-04       Impact factor: 91.245

8.  An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital.

Authors:  A S Breathnach; A de Ruiter; G M Holdsworth; N T Bateman; D G O'Sullivan; P J Rees; D Snashall; H J Milburn; B S Peters; J Watson; F A Drobniewski; G L French
Journal:  J Hosp Infect       Date:  1998-06       Impact factor: 3.926

9.  Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice.

Authors:  D J Ordway; M G Sonnenberg; S A Donahue; J T Belisle; I M Orme
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

10.  The intrinsic transmission dynamics of tuberculosis epidemics.

Authors:  S M Blower; A R McLean; T C Porco; P M Small; P C Hopewell; M A Sanchez; A R Moss
Journal:  Nat Med       Date:  1995-08       Impact factor: 53.440

View more
  99 in total

Review 1.  Drug-resistant tuberculosis: what do we do now?

Authors:  A Telenti; M Iseman
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

2.  Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India.

Authors:  C Mani; N Selvakumar; S Narayanan; P R Narayanan
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

3.  Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay.

Authors:  Cengiz Cavusoglu; Suleyha Hilmioglu; Sevinc Guneri; Altinay Bilgic
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

4.  Models to understand the population-level impact of mixed strain M. tuberculosis infections.

Authors:  Rinat Sergeev; Caroline Colijn; Ted Cohen
Journal:  J Theor Biol       Date:  2011-04-16       Impact factor: 2.691

5.  The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.

Authors:  Gwenan M Knight; Caroline Colijn; Sourya Shrestha; Mariam Fofana; Frank Cobelens; Richard G White; David W Dowdy; Ted Cohen
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

6.  Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants.

Authors:  Emma Huitric; Jim Werngren; Pontus Juréen; Sven Hoffner
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

7.  Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence.

Authors:  A J O'Neill; T Huovinen; C W G Fishwick; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

8.  Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations.

Authors:  J L Klein; T J Brown; G L French
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  Mutations in cytochrome b resulting in atovaquone resistance are associated with loss of fitness in Plasmodium falciparum.

Authors:  Jennifer M Peters; Nanhua Chen; Michelle Gatton; Michael Korsinczky; Elizabeth V Fowler; Sergio Manzetti; Allan Saul; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 10.  Tuberculosis: drug resistance, fitness, and strategies for global control.

Authors:  Erik C Böttger; Burkhard Springer
Journal:  Eur J Pediatr       Date:  2007-11-07       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.